Grasela DM - Search Results

1

Garenoxacin pharmacokinetics in subjects with renal impairment.

Krishna G, Gajjar D, Swan S, Marbury T, Grasela DM, Wang Z. Krishna G, et al. Among authors: grasela dm. Curr Med Res Opin. 2007 Mar;23(3):649-57. doi: 10.1185/030079906X167679. Curr Med Res Opin. 2007. PMID: 17355746 Clinical Trial.

2

Nasogastric administration of garenoxacin as crushed tablets with and without concomitant enteral feeding in healthy subjects.

Krishna G, Noveck R, Vargas R, Grasela D, Wang Z. Krishna G, et al. Drugs R D. 2007;8(1):43-50. doi: 10.2165/00126839-200708010-00004. Drugs R D. 2007. PMID: 17249848 Clinical Trial.

3

The effect of omeprazole on the bioavailability and safety of garenoxacin in healthy volunteers.

Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z. Krishna G, et al. Among authors: grasela dm. J Clin Pharmacol. 2007 May;47(5):628-32. doi: 10.1177/0091270006299136. Epub 2007 Mar 29. J Clin Pharmacol. 2007. PMID: 17395892 Clinical Trial.

4

Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.

Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z. Krishna G, et al. Among authors: grasela dm. Pharmacotherapy. 2007 Jul;27(7):963-9. doi: 10.1592/phco.27.7.963. Pharmacotherapy. 2007. PMID: 17594201 Clinical Trial.

5

Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.

Wang Z, Grasela DM, Krishna G. Wang Z, et al. Among authors: grasela dm. Clin Ther. 2007 Jun;29(6):1098-106. doi: 10.1016/j.clinthera.2007.06.015. Clin Ther. 2007. PMID: 17692724 Clinical Trial.

6

Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.

Gajjar DA, Bello A, Ge Z, Christopher L, Grasela DM. Gajjar DA, et al. Among authors: grasela dm. Antimicrob Agents Chemother. 2003 Jul;47(7):2256-63. doi: 10.1128/AAC.47.7.2256-2263.2003. Antimicrob Agents Chemother. 2003. PMID: 12821477 Free PMC article. Clinical Trial.

7

Effect of a high-fat meal on the pharmacokinetics of the des-F(6)-quinolone BMS-284756.

Gajjar DA, Sukoneck SC, Bello A, Ge Z, Christopher L, Grasela DM. Gajjar DA, et al. Among authors: grasela dm. Pharmacotherapy. 2002 Feb;22(2):160-5. doi: 10.1592/phco.22.3.160.33556. Pharmacotherapy. 2002. PMID: 11837554 Clinical Trial.

8

Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections.

Van Wart S, Phillips L, Ludwig EA, Russo R, Gajjar DA, Bello A, Ambrose PG, Costanzo C, Grasela TH, Echols R, Grasela DM. Van Wart S, et al. Among authors: grasela dm, grasela th. Antimicrob Agents Chemother. 2004 Dec;48(12):4766-77. doi: 10.1128/AAC.48.12.4766-4777.2004. Antimicrob Agents Chemother. 2004. PMID: 15561855 Free PMC article.

9

A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.

Gajjar DA, LaCreta FP, Uderman HD, Kollia GD, Duncan G, Birkhofer MJ, Grasela DM. Gajjar DA, et al. Among authors: grasela dm. Pharmacotherapy. 2000 Jun;20(6 Pt 2):49S-58S. doi: 10.1592/phco.20.8.49s.35186. Pharmacotherapy. 2000. PMID: 10850521 Clinical Trial.

10

Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin.

Nord CE, Meurling L, Russo RL, Bello A, Grasela DM, Gajjar DA. Nord CE, et al. Among authors: grasela dm. J Chemother. 2003 Jun;15(3):244-7. doi: 10.1179/joc.2003.15.3.244. J Chemother. 2003. PMID: 12868550 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters